UNSPSC 85724508: Revision of nonautologous tissue substitute in right sacroiliac joint, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in right sacroiliac joint, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SW70KZ

UNSPSC 85724508 Revision of nonautologous tissue substitute in right sacroiliac joint, open approach (Commodity) shows minimal alignment with recent state and local procurement activity. The code's nominal scope addresses a specific surgical procedure, but the recent opportunities posted under this code comprise independent medical evaluation services, occupational medical surveillance, pharmacy benefit management, health professional staffing pools, surgical care center-of-excellence networks, and youth detention medical services—none of which involve tissue substitute revision or sacroiliac joint procedures. The mismatch suggests this code is either rarely used by state and local buyers or has been misapplied to opportunities with no direct procedural connection to the tissue substitute product family.

Recent activity spans multiple issuing bodies and states with no discernible geographic concentration: the City of Phoenix Retirement Office (Arizona) solicited independent medical evaluation services for disability determinations; the Washington State Department of Transportation solicited occupational medical surveillance services across 14 ferry system locations; the City of Long Beach (California) solicited a surgical care carve-out program; Harris County Juvenile Probation Department (Texas) issued an RFI for youth detention medical services; and the County of Santa Clara Health System (California) established a temporary health professional staffing pool. A Collier County (Florida) Pharmacy Benefit Management RFP also appears under this code. These opportunities share no common thread to sacroiliac joint tissue revision and do not represent a coherent market segment under the code's intended scope.